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Background: The clinical features of myositis related with Human T-cell leukemia virus type 1 (HTLV-1) remains
unclear despite epidemiological studies suggesting inflammatory myopathy associated with the virus.
Case presentation: Here, we described the clinical presentations, muscle biopsy studies and laboratory results of
two siblings with HTLV-1-associated myelopathy / tropical spastic paraparesis (HAM/TSP) who were affected with
lumbar lordosis. Computed tomography (CT) scans demonstrated marked paraspinal muscle atrophy in both
patients. Immunohistochemical studies of biopsy tissue obtained from one of the patients revealed inflammatory
change of the muscle. Upon oral prednisolone therapy, the patient showed improvement in muscle strength and
serum creatine kinase (CK) level.
Conclusion: Myopathy or specifically axial myopathy should be considered as clinical symptom when treating the
patients with HTLV-1 infection.
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The human T-cell lymphotropic virus type 1 (HTLV-1)
causes an inflammatory disorder of the central nervous
system (CNS) termed HTLV-1-associated myelopathy/
tropical spastic paraparesis (HAM/TSP) which is charac-
terized by spastic paraparesis, urinary dysfunction, and
paresthesia. While the neuropathology of HAM/TSP has
been extensively described in the literature, the associ-
ation between an HTLV-1 infection and muscular
diseases are not well understood. HTLV-1 infection as a
possible cause of myopathy was first noticed in early epi-
demiological studies demonstrating increased prevalence
of viral antibody titer in patients with polymyositis (PM)
from Jamaica and Japan where HTLV-1 is endemic. In
1989, Morgan reported that up to 85% of Jamaican pa-
tients with polymyositis (PM) tested positive for HTLV-1
antibody [1]. This observation was also confirmed by a
subsequent study where HTLV-1 positivity was detected* Correspondence: pine@m.kufm.kagoshima-u.ac.jp
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unless otherwise stated.in 24/38 (63%) of Jamaicans patients with PM [2].
Additionally, Cupler et al. have suggested HTLV-1 as a
cause of sporadic inclusion body myositis (sIBM)
[3-5]. Japanese patient cohorts with either PM [6] or
sporadic inclusion body myositis (sIBM) also had elevated
frequency of HTLV-1 titer as compared to healthy individ-
uals in the general population [7]. Previous pathological
studies have demonstrated HTLV-1 localized to CD4+
perimysial lymphoid cells but not within muscle fiber cells
[8,9]. However, some T-cell clonotypes, including one
Tax11-19-specific clonotype were oligoclonally expanded
among muscle-infiltrating lymphocytes [10]. The mecha-
nisms of HTLV-1 related myositis in HAM/TSP patients
are still sparse.
To broaden our understanding of HTLV-1 related
diseases, we describe in this report the medical history,
clinical characteristics and laboratory findings of two
familial HAM/TSP patients with axial myopathy.
Case presentation
HAM/TSP diagnosis
Patient 1 was a 63-year-old female HAM/TSP patient
with axial myopathy, a neuromuscular disease defined byal. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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HTLV-1 infection and two older siblings, a brother who
was diagnosed with HAM/TSP (73-year-old, Patient 2)
and a sister who has been an asymptomatic carrier.
Disease duration for both patients was approximately
23 years. Our records indicated that Patient 1 had a
HTLV-1 proviral load of 414 copies/10000 PBMCs as
well as virus-specific antibody response in serum
(1:131072) and CSF (1:256); whereas, only serum HTLV-
1 antibody data was available on Patient 2. Both patients
exhibited progressive worsening of the lower extremities,
spastic muscle tone of the legs, urinary disturbance, lack
of sweating in the lower trunk and legs, marked hyper-
active deep tendon reflex and pathological reflex such as
Babinski’s, Chaddock’s reflexes. Bilateral paresthesia of
the feet and keratoconjunctivitis sicca (dry eyes) was ob-
served in Patient 1. MRI study revealed slight atrophy
typical of HAM/TSP in thoracic spinal cord of Patient 1.
Clinical feature of the siblings
In addition to HAM/TSP, the siblings were also afflicted
with noticeable myopathy. Patient 1 has had a history of
upper and lower back pains, she was admitted to the
Orthopedics Department in her 40s at which time her
serum creatine kinase (CK) level was significantly ele-
vated at 5000 IU/L which was indicative of muscle
damage. At a later hospitalization (62-year-old) due to
recurrent urinary tract infections from intermittent
self-catheterization, a Manual Muscle Testing (MMT)
neuromuscular exam of her head, neck, upper and
lower body was performed. She had normal responses
in facial muscles but the weakness of neck flexion
(MMT 4/5) and extension (4/5) as well as limitation of
neck flexion. All of muscles groups in the upper ex-
tremities were normal (5/5) with the exception of del-
toids (4/5) of both arms. Significant loss of muscle
strength was observed in several muscle groups of her
lower body including the iliopsoas (4/5), hip abductor
(4/5), hip adductor (5/5), quadriceps femoris (4/5),
hamstrings (3/5) tibialis anterior (5/5), and gastrocne-
mius (5/5) of both legs. Marked hyperactive deep ten-
don reflex and pathological reflexes are observed.
Bilateral paresthesia of her feet but not hypoesthesia
was noticed. No sweating was observed in the lower
trunk and the legs. As such, the patient had difficulty
standing without support of a guardrail and when
attempting to maintain an erect orthostatic posture,
she displayed a protruded belly and recessed back with
anterior tilt of the pelvis that was characteristic of lumbar
lordosis, an abnormal curvature of the spine. This clinical
observation was further supported by electromyography
(EMG) studies indicating fibrillation potentials and
complex repetitive discharges in the thoracic para-
spinal muscles as well as computed tomography (CT)scan demonstrating significant paraspinal muscle atrophy
(Figure 1, Case C). Electrophysiological studies, such as a
nerve conduction study (NCS), somatosensory evoked po-
tential (SEP) and magnetic evoked potentials (MEP), were
normal. A tissue biopsy was performed on her left deltoid
muscle where immunohistochemistry study showed fea-
tures of inflammatory myopathy and HTLV-1 provirus
(the tax sequence, nucleotides 7358–7516) was also de-
tected by PCR (data not shown).
Similarly, Patient 2 had a disease progression resem-
bling that of his sister with visible paraspinal muscle
weakness and lordosis as described above. He has had
prior complaints (50 year-old) of muscle weakness of his
extremities with an elevated serum CK level (>7000 IU/L).
The CK level gradually normalized thereafter. At his age
of 63, he experienced frequent urinary incontinence and
was diagnosed as having uninhibited neurogenic bladder.
He started to perform intermittent self-catheterization.
Several years later, unlike Patient 1 who was able to walk
with assistance, Patient 2 had become bed-ridden and had
difficulty sitting or maintain an upright posture. At his age
of 73, we evaluated his muscle strength and found normal
muscular strength in his upper extremities (MMT 5/5)
with the exception of the deltoid (4/5) muscles. Likewise,
muscle groups in his lower extremities only demonstrated
slight weakness and the results were as follow: iliopsoas
(4/5), hip abductor (4/5), hip adductor (4/5), quadriceps
femoris (4/5), hamstrings (4/5), tibialis anterior (5/5), and
gastrocnemius (5/5) of both legs. CT scan demonstrated
marked atrophy of paraspinal muscles and gluteus medius
and minimus (Figure 1, Case D). Marked hyperactive deep
tendon reflex and pathological reflexes are observed.
There is no sensory disturbance but sweating was not de-
tected in his legs.
Muscle CT findings
We compared the two siblings described in this report
(Table 1, Case C.D) with three of the control HAM/TSP
patients (Table 1, Cases A.B.E). One (Case B) was a
HAM/TSP patient with nearly the same duration of
disease as the other two siblings, while the other two
were the patients with shorter (Case A) and longer
(Case E) durations of disease than the two siblings.
The CT findings at several truncal levels revealed that
the three control HAM/TSP patients (Figure 1, Cases
A.B.E) gradually developed muscle wasting of the para-
spinal muscles, iliopsoas and gluteus muscles in pro-
portion to the duration of disease. In contrast, the two
siblings (Case C.D) showed severe atrophy limited to
the paraspinal muscles with well-preserved iliopsoas
and gluteus maximus muscles. The elder brother (Case D)
also showed severe atrophy of the gluteus medius and
minimus, which helps to explain his difficulty in maintain-
ing a standing posture.
Figure 1 Atrophy in paraspinal muscles of the siblings. (A-E) Computed tomography studies of 5 patients with HAM/TSP at several truncal
levels (upper thoracic, lower thoracic, lumbar and sacral levels). (A, B, E) The degree of muscle atrophy of the control HAM/TSP patients was in
accordance with the duration of HAM/TSP. (C, D) The two siblings showed extreme atrophy of the paraspinal muscles (arrow) in comparison to
the iliopsoas muscles (IP). The difference in atrophy between iliopsoas and paraspinal muscle of the two siblings is conspicuous in comparison to
case B with similar disease duration. (D) The gluteus medius and minimus (arrow head) were also selectively atrophied in the elder brother. PS,
paraspinal muscles; IP, iliopsoas; MAX, gluteus maximus; MED, gluteus medius; MIN, gluteus minimus.
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course of patient 1
Since myopathy in HAM/TSP patients is rarely described,
we performed extensive laboratory analysis and whole
genome molecular sequencing to rule out other causes of
her disease. At the time of hospital admission (62-year-
old), Patient 1 had a body mass index that was within the
normal range (height = 159 cm; weight = 50 kg) and regu-
lar bowel movements. Except for a slightly elevated serum
CK level of 187 IU/L (normal, 45–163 IU/L), CBC, urin-
alysis, total protein, electrolytes, bilirubin, cholesterol, al-
kaline phosphatase, lactate dehydrogenase, CRP, ESR, and
thyroid hormone levels were unremarkable. Consistent
with prior complaints of eye dryness and bilaterally posi-
tive Schirmer’s test, eye examination revealed superficial
keratitis and corneal opacity. Other autoimmune connect-
ive tissue disorders such as rheumatoid arthritis andTable 1 Duration and status of the patients with HAM/TSP as
Case Age Sex Duration of disease
A 67 M 10 years
B 75 F 21 years
C 63 F 23 years (Case 1)
D 73 M 23 years (Case 2)
E 53 F 30 yearssystemic lupus erythematosus as possible causes of her
condition were excluded based on the test results of the
autoantibody panel. Moreover, since the patient’s older
brother (Patient 2) has spastic paraplegia and was also di-
agnosed with HAM/TSP, we questioned whether genetic
mutation could be a contributing factor of their condition.
DNA from Patient 1 was used in whole-exome analysis
but no causative mutations were identified among
the known disease-causing genes of inherited spastic
paraplegia.
This patient was treated with oral prednisolone
(50 mg/day) for three days. Upon treatment, she showed
improvement in weakness and limitation of neck flexion,
and weakness in deltoid and quadriceps femoris muscles.
Although the abnormality in the curvature of her spine
was somewhat reduced suggested by decreased protrusion
of her belly following steroid treatment, her condition ofshown in Figure 1
Onset subject Status EDSS score
Gait disturbance Walking with stick 6.5
Gait disturbance Bedridden 9.0
High back pain Walking with stick 6.0
Low back pain Bedridden 8.5
Gait disturbance Wheelchair 7.0
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a tapered therapy with a10 mg/week decrease of prednis-
olone dosage and maintained a long-term therapy of
5 mg/day. During her follow-up examination, she was able
to walk without a guardrail and her serum CK level was
well within normal range at 32 IU/L.
Muscle pathology and HTLV-1 detection
A biopsy of the left deltoid muscle in Patient 1 was per-
formed and used for histochemical studies and HTLV-1
detection. A pathological study of the biopsied muscle
revealed that muscle fibers ranged from 8 to 80 microns
in diameter and had slight increase in the number of
internal nuclei. Mononuclear inflammatory cells were
observed in the endomysium, perimysium and around
the vessels (Figure 2A). Occasional degeneration fibers
having varying levels of oxidative enzyme activities was
observed in the NADH tetrazolium reductase reacted
sections. As judged from the ATPase reacted sections,
the random checkerboard distribution of the histochem-
ical fiber types was preserved. No rimmed vacuoles wereFigure 2 Muscle biopsy. Biopsy findings of the left deltoid muscle in Pati
cells were observed in the endomysium, perimysium and around the vesse
observed in the endomysium. (C) An expression of HLA-ABC was markedly
of muscle tissue (D) A non-necrotic muscle fiber is surrounded by CD3+ ly
and CD8+ lymphocytes. Bar = 100 μm.observed with modified Gomori Trichrome staining.
The acid phosphatase activity was increased in the invad-
ing macrophages. Immunohistochemical study revealed
that CD4-positive lymphocytes and CD8-positive lympho-
cytes surrounding a non-necrotic fiber (Figure 2B) and
elevated expression of HLA-ABC in the membrane of
muscle fibers (Figure 2C). These findings are compatible
with inflammatory myopathy.
In addition, DNA was extracted from the muscle
(DNeasy tissue kit, QIAGEN, Tokyo, Japan) for virus de-
tection. HTLV-1 SK43 and SK44 primers were used for
tax DNA fragment. HTLV-1 provirus (the tax sequence,
nucleotides 7358–7516) was detected by PCR, with some
modification (Data not shown) [11].
Genetic analysis for hereditary spastic paraparesis
Genomic DNA from the PBMC of Patient 1 was used
in whole-exome sequencing analysis. Purified DNA
was amplified using the Ion AmpliSeq Exome Kit (Life
Technologies, Carlsbad, CA, U.S.A.), and sequenced
on a Proton PI chip Version 2 (Life Technologies)ent 1. (A) Hematoxylin and eosin staining. Mononuclear inflammatory
ls. (B) Infiltrations of CD3-positive lymphocytes were occasionally
increased in the membrane of muscle fibers. (D-F) Sequential section
mphocytes. (E, F) The lymphocytic infiltrates were composed of CD4+
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and variant detection was performed using the Torrent
Suite™ software with default parameters. No causative mu-
tations were identified among the known disease-causing
genes of inherited spastic paraplegia.
Discussion
The most characteristic finding of the siblings with
HAM/TSP was the remarkable wasting of the paraspinal
muscles contrary to well-preserved iliopsoas muscle, glu-
teus muscles and the muscles of the extremities. Back
pain as an initial symptom of the patient may suggest
such condition. Paraspinal muscle atrophy to some de-
gree is seen in various conditions such as amyotrophic
lateral sclerosis, myasthenia gravis, muscular dystrophy,
isolated extensor myopathy, sporadic inclusion body
myositis, mitochondrial dysfunction, and axial myopathy.
The immunohistochemical findings and fair improve-
ments of her muscle weakness, limitation of neck flexion
and serum CK level with oral prednisolone therapy
strongly suggest they have both HAM/TSP and unique ac-
quired inflammatory myopathy, although the possibility
that the siblings may have unknown hereditary muscular
diseases still remains.
Previous clinical or pathological studies have shown
myopathic features in HTLV-1-infected individuals.
Unique clinical manifestations were reported in HTLV-
infected patients with inflammatory myopathy. Hokezu
et al. also reported that the two sisters with myositis
and HTLV-1 infection walked protruding their belly
with a lordosis [12]. Littleton et al. reported HTLV-1-
positive patient with rimmed vacuoles presenting with
respiratory failure [13]. Honma et al. reported HAM/
TSP patient with rimmed vacuoles presenting waddling
gait [14]. Matsuura et al. reported that waddling gait
was seen in 6 of 11 HTLV-1-positive patients with sIBM
[7]. Inflammatory myopathy with HTLV-1 infection
might show unique manifestation involving axial muscles
in some cases. Although clinical symptom of the patients
with HAM/TSP is spastic paraparesis, immunohistochem-
ical studies on the muscles of HAM/TSP patients have re-
vealed inflammatory or non-inflammatory myopathic
change in over 50% of HAM/TSP patients [15,16]. The
other study has shown that HTLV-1-positive patients with
polymyositis had frequent cytochrome c oxidase defi-
ciency and ultrastructural abnormalities in mitochondria
of the affected muscle [17]. Sakiyama et al. reported the
cases with a mitochondrial abnormality presenting axial
myopathy, although the case was not infected to HTLV-1
[18]. Some patients with HTLV-1 infection and mitochon-
drial dysfunction might have association with axial myop-
athy, although any vacuoles, aggregates and mitochondrial
pathology were not observed in biopsied muscle of our
patient.Conclusion
Our patient with HAM/TSP showed a fair improvement
of muscles’ weakness, limitation of neck flexion and
standing posture with prednisolone therapy. Inflamma-
tory myopathy or specifically axial myopathy should be
considered as clinical symptom when treating the pa-
tients with HAM/TSP. A better understanding the site
of lesion would lead to more appropriate medical treat-
ment or physical therapy, resulting in delaying or min-
imizing the progressive neurological deficits seen in
HAM/TSP patients.
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